Leaflet REBETRON R 200mg / 3MUI / 0.5ml capsules and solution for injection
Indicated for: chronic hepatitis C
Route of administration: injectable
Substance: ribavirin + interferon alfa 2B (antivirals)
ATC: J05AB54 (Antiinfectives for systemic use | Direct acting antivirals | Nucleosides and nucleotides excl. reverse transcriptase inhibitors)
Dose adjustment may be needed in kidney disease.
This medicine may have important interactions with other medicines.
The combination of ribavirin and interferon alfa-2B is used for the treatment of chronic hepatitis C. Ribavirin inhibits viral replication, while interferon alfa-2B enhances the body's immune response against the virus.
The medication is administered orally (ribavirin) and by injection (interferon alfa-2B), as directed by a doctor. It is important for patients to follow the treatment regimen and undergo regular check-ups to monitor the therapy's effectiveness and side effects.
Patients should be aware of potential side effects, such as anemia, fatigue, flu-like symptoms, or depression. It is important to inform the doctor of any unusual symptoms.
Common side effects include anemia, fatigue, flu-like symptoms, and skin irritation. In rare cases, severe reactions such as severe depression or liver dysfunction may occur. Patients should be informed of these risks before use.
General data about REBETRON R 200mg / 3MUI / 0.5ml
- Substance: ribavirin + interferon alfa 2B
- Date of latest medicines list: 01-07-2013
- Product code: W10137001
- Concentration: 200mg / 3MUI / 0.5ml
- Pharmaceutical form: capsules and solution for injection
- Quantity: 1
- Product type: Generic medicine
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.